Compare TransMedics Group Inc (TMDX) vs Uranium Energy Corp (UEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TransMedics Group Inc vs Uranium Energy Corp — how do they compare? TransMedics Group Inc trades at $77.87 (market cap $2.74B), while Uranium Energy Corp trades at $9.19 (market cap $4.53B). The key difference: Uranium Energy Corp is the larger of the two by market cap, and TransMedics Group Inc is trading nearer its 52-week high, Uranium Energy Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold TransMedics Group Inc for 24 Days and Uranium Energy Corp for 37 Days on average.
| TMDX | UEC | |
|---|---|---|
Market Cap | $2.74B | $4.53B |
Volume | 949,331 | 10,888,578 |
Sector | Health | Energy |
52-Week High | $150.42 | $20.14 |
52-Week Low | $61.99 | $9.04 |
Typical Hold Time | 24 Days | 37 Days |
Enterprise Value | $3.13B | $4.03B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TransMedics Group (TMDX) trades at $79.00, down 2.55% amid bearish technical signals and mixed earnings performance. The stock shows strong fundamentals with 58.69% gross margins and 22.69% net income margins, though profitability declined year-over-year. Recent news highlights insider buying, CFO appointment, and ongoing legal investigations into fiduciary duties, creating conflicting sentiment signals.
While analyst consensus remains bullish with a $99.75 price target, near-term risks include margin pressure from heavy investments and legal uncertainties. The stock's current valuation at 20.47 P/E offers potential upside if execution improves, but investors face volatility from earnings misses and regulatory scrutiny.
Uranium Energy (UEC) trades at $9.14, down 3.48% in the last session, amid bearish technical signals despite strong analyst support. The company reported fiscal 2026 revenue of $37 million but posted a net loss of $137 million, reflecting ongoing operational challenges. Recent news highlights UEC's expansion to two operating mines and strong uranium pricing at $93.13 per pound, though production sustainability remains unproven. Technical indicators show bearish momentum with resistance at $10 and support at $9.
UEC presents a high-risk opportunity with significant analyst optimism (87.5% buy ratings) and a consensus price target of $16.06, offering 75% upside potential. However, persistent negative earnings, cash flow challenges, and dependence on uranium market dynamics pose substantial risks. Investors should weigh the company's strategic positioning in domestic uranium production against its current financial performance and execution risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →About Uranium Energy Corp
Uranium Energy Corp is a leading American uranium mining and exploration company, currently holding the largest resource base and licensed production capacity in the United States. Utilizing low-cost, environmentally friendly In-Situ Recovery (ISR) mining, UEC is a central player in the domestic nuclear fuel supply chain, transitioning from a resource holder to an active producer and refiner to meet the accelerating demand for carbon-free energy.
Read more on UEC →
